Activity of KRM-1648, a New Benzoxazinorifamycin, Against Mycobacterium Tuberculosis in a Murine Model.

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.38.10.2245
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology


Related search